The Role of PET-CT in Radiotherapy Planning of Solid Tumours

Overview

Journal Radiol Oncol

Publisher Sciendo

Specialties Oncology
Radiology

Date 2015 Mar 27

PMID 25810695

Citations 9

Authors

Stasa Jelercic

Mirjana Rajer

Affiliations

Soon will be listed here.

Abstract

Background: PET-CT is becoming more and more important in various aspects of oncology. Until recently it was used mainly as part of diagnostic procedures and for evaluation of treatment results. With development of personalized radiotherapy, volumetric and radiobiological characteristics of individual tumour have become integrated in the multistep radiotherapy (RT) planning process. Standard anatomical imaging used to select and delineate RT target volumes can be enriched by the information on tumour biology gained by PET-CT. In this review we explore the current and possible future role of PET-CT in radiotherapy treatment planning. After general explanation, we assess its role in radiotherapy of those solid tumours for which PET-CT is being used most.

Conclusions: In the nearby future PET-CT will be an integral part of the most radiotherapy treatment planning procedures in an every-day clinical practice. Apart from a clear role in radiation planning of lung cancer, with forthcoming clinical trials, we will get more evidence of the optimal use of PET-CT in radiotherapy planning of other solid tumours.

Citing Articles

Estimation of the Internal Dose Imparted by F-Fluorodeoxyglucose to Tissues by Using Fricke Dosimetry in a Phantom and Positron Emission Tomography.

Tippayamontri T, Betancourt-Santander E, Guerin B, Lecomte R, Paquette B, Sanche L Front Nucl Med. 2024; 2:815141.

PMID: 39354965 PMC: 11440868. DOI: 10.3389/fnume.2022.815141.

Tumor-tropic Trojan horses: Using mesenchymal stem cells as cellular nanotheranostics.

Rosu A, Ghaemi B, Bulte J, Shakeri-Zadeh A Theranostics. 2024; 14(2):571-591.

PMID: 38169524 PMC: 10758060. DOI: 10.7150/thno.90187.

A deep learning approach for automatic tumor delineation in stereotactic radiotherapy for non-small cell lung cancer using diagnostic PET-CT and planning CT.

Yu X, He L, Wang Y, Dong Y, Song Y, Yuan Z Front Oncol. 2023; 13:1235461.

PMID: 37601687 PMC: 10437048. DOI: 10.3389/fonc.2023.1235461.

Changing Role of PET/CT in Cancer Care With a Focus on Radiotherapy.

Vijayakumar S, Yang J, Nittala M, Velazquez A, Huddleston B, Rugnath N Cureus. 2023; 14(12):e32840.

PMID: 36694538 PMC: 9867792. DOI: 10.7759/cureus.32840.

The Role of Positron Emission Tomography and Computed Tomographic (PET/CT) Imaging for Radiation Therapy Planning: A Literature Review.

Mallum A, Mkhize T, Akudugu J, Ngwa W, Vorster M Diagnostics (Basel). 2023; 13(1).

PMID: 36611345 PMC: 9818506. DOI: 10.3390/diagnostics13010053.

References

Yoon M, Ahn S, Nah B, Chung W, Song H, Yoo S . Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography. Int J Radiat Oncol Biol Phys. 2012; 84(4):e491-7. DOI: 10.1016/j.ijrobp.2012.05.041. View

Haerle S, Schmid D, Ahmad N, Hany T, Stoeckli S . The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma. Oral Oncol. 2011; 47(7):653-9. DOI: 10.1016/j.oraloncology.2011.05.011. View

Dirix P, Vandecaveye V, De Keyzer F, Stroobants S, Hermans R, Nuyts S . Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med. 2009; 50(7):1020-7. DOI: 10.2967/jnumed.109.062638. View

Vrieze O, Haustermans K, De Wever W, Lerut T, Van Cutsem E, Ectors N . Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?. Radiother Oncol. 2004; 73(3):269-75. DOI: 10.1016/j.radonc.2004.10.001. View

Strojan P, Ferlito A, Medina J, Woolgar J, Rinaldo A, Robbins K . Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck. 2011; 35(1):123-32. DOI: 10.1002/hed.21898. View

Steenbakkers R, Duppen J, Fitton I, Deurloo K, Zijp L, Comans E . Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Int J Radiat Oncol Biol Phys. 2005; 64(2):435-48. DOI: 10.1016/j.ijrobp.2005.06.034. View

Kidd E, Siegel B, Dehdashti F, Rader J, Mutch D, Powell M . Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010; 28(12):2108-13. DOI: 10.1200/JCO.2009.25.4151. View

Inokuchi H, Kodaira T, Tachibana H, Nakamura T, Tomita N, Nakahara R . Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal.... Int J Radiat Oncol Biol Phys. 2010; 79(3):747-55. DOI: 10.1016/j.ijrobp.2009.11.034. View

Mitchell D, Snyder B, Coakley F, Reinhold C, Thomas G, Amendola M . Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol. 2006; 24(36):5687-94. DOI: 10.1200/JCO.2006.07.4799. View

10.

Xu G, Guan D, He Z . (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Oral Oncol. 2011; 47(7):560-5. DOI: 10.1016/j.oraloncology.2011.04.021. View

11.

Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier J, Petegnief Y . Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005; 63(5):1432-41. DOI: 10.1016/j.ijrobp.2005.05.016. View

12.

Duprez F, De Neve W, De Gersem W, Coghe M, Madani I . Adaptive dose painting by numbers for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010; 80(4):1045-55. DOI: 10.1016/j.ijrobp.2010.03.028. View

13.

Mac Manus M, Hicks R, Matthews J, Wirth A, Rischin D, Ball D . Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure. Lung Cancer. 2005; 49(1):95-108. DOI: 10.1016/j.lungcan.2004.11.024. View

14.

Boughanim M, Leboulleux S, Rey A, Pham C, Zafrani Y, Duvillard P . Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol. 2008; 26(15):2558-61. DOI: 10.1200/JCO.2007.14.3933. View

15.

Soto D, Kessler M, Piert M, Eisbruch A . Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers. Radiother Oncol. 2008; 89(1):13-8. PMC: 2684445. DOI: 10.1016/j.radonc.2008.05.021. View

16.

Magne N, Chargari C, Vicenzi L, Gillion N, Messai T, Magne J . New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET. Cancer Treat Rev. 2008; 34(8):671-81. DOI: 10.1016/j.ctrv.2008.08.003. View

17.

Kidd E, Siegel B, Dehdashti F, Rader J, Mutic S, Mutch D . Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2009; 77(4):1085-91. DOI: 10.1016/j.ijrobp.2009.06.041. View

18.

Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G . Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol. 2010; 28(7):1190-5. DOI: 10.1200/JCO.2009.24.6298. View

19.

Madani I, Duthoy W, Derie C, De Gersem W, Boterberg T, Saerens M . Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2007; 68(1):126-35. DOI: 10.1016/j.ijrobp.2006.12.070. View

20.

Schwarz J, Siegel B, Dehdashti F, Grigsby P . Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA. 2007; 298(19):2289-95. DOI: 10.1001/jama.298.19.2289. View